- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Congress takes on FDA’s PET regulation
The Food and Drug Administration's regulation of radioisotopes used in PET imaging has drawn the ire of Congress. Three members of the House of Representatives are circulating a "Dear Colleague" letter that urges support for legislation that would
The Food and Drug Administration's regulation of radioisotopes used in PET imaging has drawn the ire of Congress. Three members of the House of Representatives are circulating a "Dear Colleague" letter that urges support for legislation that would expressly remove the FDA's authority to regulate PET products.
The FDA has ruled that it has the authority to regulate PET radioisotopes produced in cyclotrons, and has proposed regulations requiring each isotope-producing site to receive new drug applications (NDAs) or abbreviated NDAs before their products can be used clinically. Opponents of the FDA's policy, however, believe that PET radioisotopes should be regulated under state practice of pharmacy rules. The FDA's policy prompted radiopharmacy firm Syncor International of Chatsworth, CA, to file suit against the FDA in 1995. A U.S. District Court decided in favor of the FDA late last year (SCAN 2/5/97).
The Dear Colleague letter was issued Feb. 27 by Rep. Richard Burr (R-NC), Rep. Gary Condit (D-CA), and Rep. Tom DeLay (R-TX). They are soliciting co-sponsors for the Pharmacy Compounding Act of 1997 (HR 1060), which would give the states regulatory authority over pharmacy compounding. It also includes a section that would withdraw the FDA's regulations regarding PET radioisotopes.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
